 |
|
Incidence of  -Lactam–Induced Delayed Hypersensitivity and Neutropenia During Treatment of Infective Endocarditis
Lars Olaison, MD, PhD;
Lars Belin, MD, PhD;
Harriet Hogevik, MD, PhD;
Kjell Alestig, MD, PhD
Arch Intern Med. 1999;159:607-615.
Background Long-term parenteral  -lactam treatment is often complicated by adverse reactions that necessitate drug withdrawal.
Objective To evaluate the incidence and mechanism of -lactam adverse reactions during an 8-year period in all episodes of suspected infective endocarditis in patients treated at a university-affiliated institution.
Methods Patients with 215 consecutive episodes of -lactam treatment for 10 days or more were prospectively enrolled during 2 periods, January 1984 through December 1988 and January 1993 through December 1995, and compared with 51 episodes of vancomycin hydrochloride treatment for 10 days or more. Incidents of adverse reactions, such as fever, rash, or neutropenia, were registered. Neutrophil counts, eosinophil counts, and penicillin antibodies were studied. Patients with delayed adverse reactions to penicillin G sodium were rechallenged with penicillin v potassium.
Results Incidence of delayed adverse reactions during treatment was 33% with -lactams compared with 4% with vancomycin. Rates of adverse event for -lactams increased continuously from treatment day 15 to day 30. A 6-fold difference in capacity to induce adverse events was found with different -lactams. Penicillin G induced neutropenia in 14% and any adverse event in 51% of treated episodes. Mean daily doses significantly influenced the frequency of adverse events. Occurrence of hemagglutinating penicillin antibodies was significantly related to patients whose penicillin-treated episodes were complicated with adverse events. Patients with delayed adverse reactions to penicillin G were safely rechallenged with penicillin.
Conclusions Incidence of delayed adverse reactions to -lactams increases sharply when parenteral treatment is extended beyond 2 weeks. Penicillin G is the most frequent inducer of adverse reactions among -lactams studied. An immunological reaction mediated by antibodies to the penicilloyl determinant may be involved in the pathogenesis, possibly enhanced by a dose-related toxic trigger mechanism. -Lactam–induced neutropenia followed a uniform pattern, occurring after, on average, 21 days of treatment, and might be due to both immunologic and toxic effects of treatment. Patients with a late adverse reaction to penicillin can safely be re-treated with penicillin, although they should remain under close surveillance if treatment extends beyond 2 weeks.
From the Department of Infectious Diseases (Drs Olaison, Hogevik, and Alestig) and Division of Allergy (Dr Belin), Institute of Internal Medicine, Göteborg University, Sahlgrenska University Hospital, Göteborg, Sweden.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED LETTER
Drug-Induced Allergic Cytopenia: In Vitro Confirmation by the Lymphocyte Transformation Test
Bernhardt Sachs, Stephan Erdmann, Iris Borchardt, Peter Drüke, Hans Friedrich Merk, and Jan Palmblad
Arch Intern Med. 2000;160(14):2218-2219.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Antibiotic Treatment of Mycobacterium abscessus Lung Disease: A Retrospective Analysis of 65 Patients
Jeon et al.
Am. J. Respir. Crit. Care Med. 2009;180:896-902.
ABSTRACT
| FULL TEXT
Cephalosporin-Induced Leukopenia Following Rechallenge with Cefoxitin
Whitman et al.
The Annals of Pharmacotherapy 2008;42:1327-1332.
ABSTRACT
| FULL TEXT
Drug-Induced Allergic Cytopenia: In Vitro Confirmation by the Lymphocyte Transformation Test
Sachs et al.
Arch Intern Med 2000;160:2218-2219.
FULL TEXT
|
